Karin Eklund Vanderpol
Nessuna posizione attualmente
Profilo
Karin Eklund Vanderpol formerly worked at Swedish Orphan Biovitrum AB, as Director-Global Regulatory Affairs, AstraZeneca AB, as Head-Regulatory Affairs, and Oncopeptides AB, as Head-Regulatory Affairs from 2020 to 2022.
Ms. Vanderpol received her graduate degree from the University of Uppsala.
Precedenti posizioni note di Karin Eklund Vanderpol
| Società | Posizione | Fine |
|---|---|---|
| ONCOPEPTIDES AB | Consigliere Generale | 01/01/2022 |
| SWEDISH ORPHAN BIOVITRUM AB | Consigliere Generale | 01/12/2019 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Consigliere Generale | - |
Formazione di Karin Eklund Vanderpol
| University of Uppsala | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ONCOPEPTIDES AB | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Aziende private | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Borsa valori
- Insiders
- Karin Eklund Vanderpol